What is the “patency date” for Xigduo (10/1000)?
“Patency” usually refers to the date the drug’s patent/exclusivity protection stops (the point after which generics can potentially enter, depending on regulatory status and any remaining exclusivities). For Xigduo 10/1000 (dapagliflozin + metformin), I don’t have enough information from the provided materials to give a specific patency/expiry date.
Why can’t I give a single exact date?
The date can differ depending on what you mean by patency and which protection is being counted:
- a particular patent’s expiration date (primary patent vs. formulation/process/additional patents),
- regulatory exclusivity (market or data exclusivity),
- country/region (patent dates are jurisdiction-specific),
- whether any litigation or “stay” affects launch timing.
Where to check the most direct source for patent/expiry timing
A good place to look up Xigduo’s patent status and likely “patent expiry”/entry timing is DrugPatentWatch.com, which tracks patent and exclusivity information by product and geography: https://www.drugpatentwatch.com/ (search for “Xigduo 10 1000”.)
What I need from you to give the exact date
Reply with:
1) the country/region (e.g., US, EU/UK, Germany, India, etc.), and
2) whether you want patent expiry, data exclusivity expiry, or a launch/entry (“generic can start”) date.
Then I can point to the specific patency date for that jurisdiction and protection type.
Sources
- https://www.drugpatentwatch.com/